By Devika Patel
Knoxville, Tenn., Nov. 20 - Infinity Pharmaceuticals, Inc. announced a $75 million private placement of stock in an 8-K filed Wednesday with the Securities and Exchange Commission.
At pricing, the company sold 4 million common shares at $11.25 per share to Purdue Pharma LP and Purdue Pharmaceutical Products LP for $45 million. The investors also will buy 2 million shares and warrants for 6 million shares in a second tranche for $30 million.
Of the warrants, a portion are exercisable for 500,000 shares at $15.00 until July 1, 2010, with an exercise price that increases over time to a maximum strike price of $20.00. Some of the warrants are exercisable for 1 million shares at $20.00 until July 1, 2011, with an exercise price that increases over time to a maximum strike price of $30.00. The remainder of warrants will be exercisable for 1.5 million shares at $30.00 until July 2, 2012, with an exercise price that increases over time to a maximum strike price of $40.00.
The deal was arranged Nov. 19.
Infinity is a Cambridge, Mass., pharmaceutical company working on cancer treatments.
Issuer: | Infinity Pharmaceuticals, Inc.
|
Issue: | Common stock
|
Amount: | $75 million
|
Investors: | Purdue Pharma LP and Purdue Pharmaceutical Products LP
|
Pricing date: | Nov. 19
|
Stock symbol: | Nasdaq: INFI
|
Stock price: | $5.29 at close Nov. 19
|
|
First tranche
|
Amount: | $45 million
|
Shares: | 4 million
|
Price: | $11.25
|
Warrants: | No
|
Settlement date: | Nov. 19
|
|
Second tranche
|
Amount: | $30 million
|
Shares: | 2 million
|
Warrants: | For 6 million shares
|
Warrant expiration: | Varying, from July 1, 2010 through July 2, 2012
|
Warrant strike price: | Varying and subject to adjustment, from $15.00 to $40.00
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.